256 related articles for article (PubMed ID: 17114343)
1. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
2. Promiscuous partnerships in Ewing's sarcoma.
Sankar S; Lessnick SL
Cancer Genet; 2011 Jul; 204(7):351-65. PubMed ID: 21872822
[TBL] [Abstract][Full Text] [Related]
3. BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
Wiles ET; Lui-Sargent B; Bell R; Lessnick SL
PLoS One; 2013; 8(3):e59369. PubMed ID: 23527175
[TBL] [Abstract][Full Text] [Related]
4. A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma.
Sankar S; Tanner JM; Bell R; Chaturvedi A; Randall RL; Beckerle MC; Lessnick SL
Mol Cell Biol; 2013 Nov; 33(22):4448-60. PubMed ID: 24043308
[TBL] [Abstract][Full Text] [Related]
5. Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma.
de Alava E; Panizo A; Antonescu CR; Huvos AG; Pardo-Mindán FJ; Barr FG; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):849-55. PubMed ID: 10702401
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis.
Urano F; Umezawa A; Yabe H; Hong W; Yoshida K; Fujinaga K; Hata J
Jpn J Cancer Res; 1998 Jul; 89(7):703-11. PubMed ID: 9738976
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the molecular pathogenesis of Ewing's sarcoma.
Toomey EC; Schiffman JD; Lessnick SL
Oncogene; 2010 Aug; 29(32):4504-16. PubMed ID: 20543858
[TBL] [Abstract][Full Text] [Related]
8. STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma.
Adane B; Alexe G; Seong BKA; Lu D; Hwang EE; Hnisz D; Lareau CA; Ross L; Lin S; Dela Cruz FS; Richardson M; Weintraub AS; Wang S; Iniguez AB; Dharia NV; Conway AS; Robichaud AL; Tanenbaum B; Krill-Burger JM; Vazquez F; Schenone M; Berman JN; Kung AL; Carr SA; Aryee MJ; Young RA; Crompton BD; Stegmaier K
Cancer Cell; 2021 Jun; 39(6):827-844.e10. PubMed ID: 34129824
[TBL] [Abstract][Full Text] [Related]
9. Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
Xiao Y; Zhi Y; Cao G; Ma H; Gao J; Li F
J Cancer Res Clin Oncol; 2024 May; 150(5):267. PubMed ID: 38769118
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.
Przybyl J; Kozak K; Kosela H; Falkowski S; Switaj T; Lugowska I; Szumera-Cieckiewicz A; Ptaszynski K; Grygalewicz B; Chechlinska M; Pienkowska-Grela B; Debiec-Rychter M; Siedlecki JA; Rutkowski P
Med Oncol; 2014 Aug; 31(8):109. PubMed ID: 25008066
[TBL] [Abstract][Full Text] [Related]
11. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system.
Torres R; Martin MC; Garcia A; Cigudosa JC; Ramirez JC; Rodriguez-Perales S
Nat Commun; 2014 Jun; 5():3964. PubMed ID: 24888982
[TBL] [Abstract][Full Text] [Related]
12. The metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kit.
Landuzzi L; De Giovanni C; Nicoletti G; Rossi I; Ricci C; Astolfi A; Scopece L; Scotlandi K; Serra M; Bagnara GP; Nanni P; Lollini PL
Am J Pathol; 2000 Dec; 157(6):2123-31. PubMed ID: 11106584
[TBL] [Abstract][Full Text] [Related]
13. Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.
Simmons O; Maples PB; Senzer N; Nemunaitis J
ISRN Oncol; 2012; 2012():247657. PubMed ID: 22523703
[TBL] [Abstract][Full Text] [Related]
14. One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.
Flores G; Grohar PJ
J Bone Oncol; 2021 Dec; 31():100404. PubMed ID: 34976713
[TBL] [Abstract][Full Text] [Related]
15. PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview.
Adibi A; Tokat ÜM; Özgü E; Aydın E; Demiray İ; Demiray M
Ther Adv Med Oncol; 2023; 15():17588359231213841. PubMed ID: 38107827
[TBL] [Abstract][Full Text] [Related]
16. Targeted Therapy of Ewing's Sarcoma.
Subbiah V; Anderson P
Sarcoma; 2011; 2011():686985. PubMed ID: 21052545
[TBL] [Abstract][Full Text] [Related]
17. Ewing's sarcoma: overcoming the therapeutic plateau.
Subbiah V; Kurzrock R
Discov Med; 2012 Jun; 13(73):405-15. PubMed ID: 22742646
[TBL] [Abstract][Full Text] [Related]
18. Is There a Predisposition Gene for Ewing's Sarcoma?
Randall RL; Lessnick SL; Jones KB; Gouw LG; Cummings JE; Cannon-Albright L; Schiffman JD
J Oncol; 2010; 2010():397632. PubMed ID: 20300555
[TBL] [Abstract][Full Text] [Related]
19. [Ewing's sarcoma of central nervous system: a clinicopathological analysis of six cases].
Yang QY; Li H; Liu C; Bao ML; Fan QH; Pan MH
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1249-1254. PubMed ID: 38058042
[No Abstract] [Full Text] [Related]
20. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.
Manara MC; Manferdini C; Cristalli C; Carrabotta M; Santi S; De Feo A; Caldoni G; Pasello M; Landuzzi L; Lollini PL; Salamanna F; Dominici S; Fiori V; Magnani M; Lisignoli G; Scotlandi K
Cancer Immunol Res; 2024 Feb; 12(2):247-260. PubMed ID: 38051221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
